American Society of Hematology Announces 2022 Scholar Award Recipients

Feb 17, 2022

(WASHINGTON, Feb. 17, 2022) — The American Society of Hematology (ASH) today announced the 36 recipients of its 2022 Scholar Awards. One of ASH’s most prestigious research award programs, the ASH Scholar Awards support fellows and junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.

Each Scholar Award provides $100,000 for the Fellow level, $125,000 for the new Fellow to Faculty Scholars level, or $150,000 for the Junior Faculty level. The program funds hematologists in the United States and Canada who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders.

“For researchers, Scholar Awards not only provide vital financial support, but also instill confidence that ASH recognizes their potential to make discoveries of importance to the field,” said 2022 ASH President, Jane N. Winter, MD, of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University’s Feinberg School of Medicine. “For more than 35 years now, ASH has supported fellows and early career faculty who have gone on to become leaders in hematology. We congratulate this year’s recipients and look forward to following the progress of their promising research careers.”

The 2022 Scholar Awards recipients are:

Basic/Translational Fellow

  • Charles Antony, PhD, Perelman School of Medicine, University of Pennsylvania
  • Danielle Atibalentja, MD, PhD, Stanford University
  • Asiri Ediriwickrema, MD, Stanford University
  • Yuhong Ma, PhD, Albert Einstein College of Medicine
  • Lucile Noyer, PhD, NYU School of Medicine
  • Suman Paul, MBBS, PhD, Johns Hopkins University School of Medicine
  • Livius Penter, MD, Dana-Farber Cancer Institute
  • Scott Peslak, MD, PhD, University of Pennsylvania
  • Rebecca Richards, MD, PhD, Stanford University
  • Jennifer SanMiguel, PhD, The Jackson Laboratory
  • Luca Tottone, PhD, Rutgers Cancer Institute of New Jersey
  • Franziska Wachter, MD, Dana-Farber/Boston Children’s Hospital, Harvard Medical School

Basic/Translational Fellow to Faculty

  • Pablo Domizi, PhD, Stanford University
  • Steven Grover, PhD, University of North Carolina at Chapel Hill
  • Eugenio Morelli, MD, Dana-Farber Cancer Institute & Harvard Medical School
  • Danitza Nebor, PhD, Baylor College of Medicine
  • Simone Riedel, PhD, Children's Hospital of Philadelphia
  • Divya Vinjamur, PhD, Boston Children’s Hospital & Harvard Medical School
  • Elvin Wagenblast, PhD, University Health Network

Basic/Translational Junior Faculty

  • Daria Babushok, MD, PhD, Perelman School of Medicine, University of Pennsylvania
  • Giada Bianchi, MD, Brigham and Women’s Hospital & Harvard Medical School
  • Bruno Di Stefano, PhD, Baylor College of Medicine
  • Radhika Gangaraju, MD, University of Alabama at Birmingham
  • Kate Markey, MBBS, PhD, Fred Hutchinson Cancer Research Center
  • Seema Patel, PhD, Emory University School of Medicine
  • Tirthadipa Pradhan-Sundd, PhD, University of Pittsburgh
  • Martin Rivas, PhD, Weill Cornell Medicine
  • Jennifer Saultz, DO, Oregon Health & Science University
  • Andrew Volk, PhD, Cincinnati Children’s Hospital Medical Center
  • Liling Wan, PhD, University of Pennsylvania

Clinical Fellow

  • Caitlin Elgarten, MD, Children’s Hospital of Philadelphia
  • Madhavi Lakkaraja, MD, MPH, Texas Children’s Hospital, Baylor College of Medicine

Clinical Fellow to Faculty

  • Beth Apsel Winger, MD, PhD, University of California, San Francisco

Clinical Junior Faculty

  • Nitya Bakshi, MBBS, MS, Emory University School of Medicine/Children's Healthcare of Atlanta
  • Kristen Sanfilippo, MD, MPHS, Washington University School of Medicine
  • Jordan Schaefer, MD, University of Michigan

ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH gratefully acknowledges this year’s corporate supporters: AstraZeneca, Bristol Myers Squibb, and Pharmacyclics LLC.

The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, and Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.

Contact:
Leah Enser, American Society of Hematology
lenser@hematology.org; 202-552-4927